Mice lacking the IL-22 receptor are more susceptible to HFD-induced obesity and IR, and treatment of obese mice with IL-22 suppresses TNF expression in adipose tissue, as well as improving IR [148]. The gene discussed is IL22; the disease is obesity disorder.